Related Experiment Video
Updated: Jun 18, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia
Kishiko Nakajima1, Kazuko Yamazaki, Hironari Kimura
1Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, Tokyo.
Abstract:
Among 15 patients with PTH-deficient idiopathic hypocalcemia, we found two novel missense mutations in the calcium-sensing receptor (CaSR). Patient 1, who developed severe hypocalcemia (5.0 mg/dL) and seizures after birth, had a heterozygous de novo missense mutation in the transmembrane domain (A844P). The patient is currently receiving a minimum dose of 1alpha-OHD(3) (0.5 microg/day) to maintain the serum calcium level at 6 mg/dL and thus prevent seizures. Patient 2 had asymptomatic hypocalcemia (7.5 mg/dL) and also had a heterozygous missense mutation in the extracellular domain (E228G). These findings suggest that gene analysis of CaSR should be performed in patients with idiopathic hypocalcemia, particularly when it occurs in the neonatal period.
Insights
Two novel calcium-sensing receptor (CaSR) mutations were identified in patients with idiopathic hypocalcemia. Genetic analysis of CaSR is recommended for neonates with unexplained low calcium levels.
Area of Science:
- Endocrinology
- Medical Genetics
Background:
- Idiopathic hypocalcemia is a rare condition characterized by low serum calcium levels without a clear cause.
- The calcium-sensing receptor (CaSR) plays a crucial role in calcium homeostasis.
Observation:
- This study investigated 15 patients diagnosed with parathyroid hormone (PTH)-deficient idiopathic hypocalcemia.
- Two patients presented with novel missense mutations in the calcium-sensing receptor (CaSR) gene.
Findings:
- Patient 1 exhibited a de novo heterozygous missense mutation (A844P) in the CaSR transmembrane domain, leading to severe neonatal hypocalcemia and seizures.
- Patient 2 carried a heterozygous missense mutation (E228G) in the CaSR extracellular domain, resulting in asymptomatic hypocalcemia.
Implications:
- These findings highlight the importance of CaSR gene mutations in the etiology of idiopathic hypocalcemia.
- Genetic testing for CaSR mutations should be considered in the diagnostic workup of idiopathic hypocalcemia, especially in the neonatal period.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Skeleton and Calcium Homeostasis
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
